诺和诺德Novo Nordisk (NVO) 2019年年度报告「NYSE」.pdf

1、Novo NordiskAnnual Report 2019ROSHNI Roshni has type 1 diabetes and lives in IndiaManagement reviewIntroducing Novo Nordisk01 Letter from the Chair02 Letter from the CEO04 Novo Nordisk at a glance06 Performance highlightsOur business08 Leading a sustainable business11 Innovative treatments and solut

2、ions for unmet needs14 Pipeline overview16 International Operations:Building a sustainable platform for accelerated growth18 North America Operations:Ready for growth in a challenging business environment20 2019 performance and 2020 outlookGovernance29 Managing risks to protect value32 Shares and ca

3、pital structure34 Corporate governance38 Board of Directors40 Executive managementConsolidated statementsConsolidated financial statements42 Income statement43 Cash flow statement44 Balance sheet45 Equity statement46 Notes to the consolidated financial statementsConsolidated social statement(Supplem

4、entary information)78 Statement of social performance78 Notes to the consolidated social statementConsolidated environmental statement(Supplementary information)84 Statement of environmental performance84 Notes to the consolidated environmental statementAdditional information87 Managements statement

5、 and Auditors reports91 More information92 Product overview Roshni lives in India,and loves her school.She is 12 years old and wants to become a doctor.Roshni was diagnosed with type 1 diabetes at the age of four.The first few months were tough.It was hard to get the blood sugar levels right.Then sh

6、e was referred to a hospital and enrolled in Novo Nordisks Changing Diabetes in Children programme,which offers free insulin,help on managing diabetes and support for her and her family.The patient portrayed in this Annual Report have participated of her own accord and solely to express her personal